• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例羊水琥珀酰丙酮水平正常的I型酪氨酸血症的基因分型

Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.

作者信息

Poudrier J, Lettre F, St-Louis M, Tanguay R M

机构信息

Centre de Recherche du CHUQ, Département de Médecine, Université Laval, Ste-Foy, Québec, Canada.

出版信息

Prenat Diagn. 1999 Jan;19(1):61-3. doi: 10.1002/(sici)1097-0223(199901)19:1<61::aid-pd455>3.0.co;2-#.

DOI:10.1002/(sici)1097-0223(199901)19:1<61::aid-pd455>3.0.co;2-#
PMID:10073910
Abstract

Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetate hydrolase and mainly affects the liver. This disease is characterized by the presence of a high level of succinylacetone. This metabolite has been used for prenatal diagnosis from amniotic fluid samples. One case with a normal level of succinylacetone in amniotic fluid has recently been described (Grenier et al., 1996). Here, we report that this patient is a compound heterozygote for two known mutations: E364X and IVS6-1g-->t. The low level of succinylacetone cannot be explained by these mutations.

摘要

I型酪氨酸血症由富马酰乙酰乙酸水解酶缺乏引起,主要影响肝脏。这种疾病的特征是存在高水平的琥珀酰丙酮。这种代谢物已被用于从羊水样本中进行产前诊断。最近描述了一例羊水中琥珀酰丙酮水平正常的病例(Grenier等人,1996年)。在此,我们报告该患者是两个已知突变E364X和IVS6-1g-->t的复合杂合子。琥珀酰丙酮的低水平无法用这些突变来解释。

相似文献

1
Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.一例羊水琥珀酰丙酮水平正常的I型酪氨酸血症的基因分型
Prenat Diagn. 1999 Jan;19(1):61-3. doi: 10.1002/(sici)1097-0223(199901)19:1<61::aid-pd455>3.0.co;2-#.
2
A case of tyrosinaemia type I with normal level of succinylacetone in the amniotic fluid.
Prenat Diagn. 1996 Mar;16(3):239-42. doi: 10.1002/(SICI)1097-0223(199603)16:3<239::AID-PD829>3.0.CO;2-W.
3
Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.遗传性酪氨酸血症的产前诊断:羊水琥珀酰丙酮的测定
Prenat Diagn. 1982 Jul;2(3):185-8. doi: 10.1002/pd.1970020307.
4
The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone.
J Inherit Metab Dis. 1984;7 Suppl 2:135-6. doi: 10.1007/978-94-009-5612-4_42.
5
Neonatal and prenatal diagnosis of hereditary tyrosinaemia.遗传性酪氨酸血症的新生儿及产前诊断
Lancet. 1983 Jun 4;1(8336):1279. doi: 10.1016/s0140-6736(83)92731-9.
6
First-trimester prenatal diagnosis of tyrosinemia type I by amniotic fluid succinylacetone determination.通过羊水琥珀酰丙酮测定进行孕早期Ⅰ型酪氨酸血症的产前诊断。
Prenat Diagn. 1990 Feb;10(2):133-4. doi: 10.1002/pd.1970100210.
7
Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
Prenat Diagn. 1984 May-Jun;4(3):187-94. doi: 10.1002/pd.1970040305.
8
Early prenatal diagnosis of hereditary tyrosinaemia.遗传性酪氨酸血症的早期产前诊断
Lancet. 1985 May 4;1(8436):1038. doi: 10.1016/s0140-6736(85)91633-2.
9
Prenatal diagnosis of hereditary tyrosinemia by determination of fumarylacetoacetase in cultured amniotic fluid cells.通过测定培养羊水细胞中的富马酰乙酰乙酸酶进行遗传性酪氨酸血症的产前诊断。
Pediatr Res. 1985 Apr;19(4):334-7. doi: 10.1203/00006450-198519040-00002.
10
The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.I型酪氨酸血症的产前和产后诊断以及通过测定富马酰乙酰乙酸酶检测携带者状态。
Scand J Clin Lab Invest Suppl. 1986;184:35-40.

引用本文的文献

1
Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1.遗传性1型酪氨酸血症中富马酰乙酰乙酸水解酶基因突变的地理和种族分布
JIMD Rep. 2015;19:43-58. doi: 10.1007/8904_2014_363. Epub 2015 Feb 15.
2
Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation.转诊接受肝移植的酪氨酸血症患儿的临床和辅助检查结果。
Int J Prev Med. 2013 Dec;4(12):1380-5.
3
Recommendations for the management of tyrosinaemia type 1.推荐 1 型酪氨酸血症的管理。
Orphanet J Rare Dis. 2013 Jan 11;8:8. doi: 10.1186/1750-1172-8-8.
4
A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation.导致遗传性酪氨酸血症的富马酰乙酰乙酸水解酶基因中的一个错义突变(Q279R)起到剪接突变的作用。
BMC Genet. 2001;2:9. doi: 10.1186/1471-2156-2-9. Epub 2001 Jun 29.
5
Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.尽管患有I型慢性酪氨酸血症,但仍长期存活的肝细胞癌。
J Inherit Metab Dis. 2000 Dec;23(8):791-804. doi: 10.1023/a:1026756501669.